Inventor · disambiguated record
David R. Corey
Also filed as: COREY DAVID · COREY DAVID R · COREY DAVID REID
21 granted patents·14 pending applications·700 citations·filing 1994–2023
95Inventor score
Top patents by PatentIndex Score
35 records- 0197US7709456B2Modulation of gene expression by oligomers targeted to chromosomal DNAUNIV TEXAS·Filed 2006·Granted May 4, 2010·146 cites·12 claims
- 0295US8222221B2Modulation of gene expression through endogenous small RNA targeting of gene promotersCOREY DAVID R·Filed 2009·Granted Jul 17, 2012·97 cites·19 claims
- 0394US7858592B2Interfering RNAs against the promoter region of P53UNIV TEXAS·Filed 2008·Granted Dec 28, 2010·38 cites·18 claims
- 0493US8324181B2Modulation of gene expression by oligomers targeted to chromosomal DNACOREY DAVID R·Filed 2010·Granted Dec 4, 2012·24 cites·19 claims
- 0590US6046307AModulation of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1997·Granted Apr 4, 2000·75 cites·11 claims
- 0690US5413504AFerrite and capacitor filtered coaxial connectorNT T INC·Filed 1994·Granted May 9, 1995·174 cites·10 claims
- 0789US9976138B2Methods and compounds useful in conditions related to repeat expansionPRAKASH THAZHA P·Filed 2012·Granted May 22, 2018·13 cites·18 claims
- 0889US6015710AModulation of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1996·Granted Jan 18, 2000·78 cites·8 claims
- 0987US8901095B2Selective inhibition of polyglutamine protein expressionCOREY DAVID R·Filed 2009·Granted Dec 2, 2014·11 cites·27 claims
- 1086US9340785B2Selective inhibition of polyglutamine protein expressionUNIV TEXAS·Filed 2014·Granted May 17, 2016·8 cites·13 claims
- 1185US9574191B2Selective inhibition of polyglutamine protein expressionCOREY DAVID R·Filed 2011·Granted Feb 21, 2017·6 cites·2 claims
- 1284US2024141348A1Allele selective inhibition of mutant c9orf72 foci expression by duplex rnas targeting the expanded hexanucleotide repeatUNIV TEXAS·Filed 2023·Application pending·0 cites
- 1378US11840690B2Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeatUNIV TEXAS·Filed 2021·Granted Dec 12, 2023·0 cites·37 claims
- 1477US6294650B1Inhibition of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1999·Granted Sep 25, 2001·30 cites·13 claims
- 1569US2024229029A9Compositions and methods for treatment of friedreich's ataxiaUNIV TEXAS·Filed 2023·Application pending·0 cites
- 1668US11795457B2Compositions and methods for treatment of Friedreich's AtaxiaUNIV TEXAS·Filed 2021·Granted Oct 24, 2023·0 cites·14 claims
- 1768US2020208154A1Allele selective inhibition of mutant c9orf72 foci expression by duplex rnas targeting the expanded hexanucleotide repeatUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1868US2023020192A1Compounds and methods for modulating c90rf72IONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1962US10538762B2Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeatUNIV TEXAS·Filed 2015·Granted Jan 21, 2020·0 cites·22 claims
- 2061US11260073B2Compounds and methods for modulating C90RF72IONIS PHARMACEUTICALS INC·Filed 2016·Granted Mar 1, 2022·0 cites·35 claims
- 2159US11512312B2Treatment of Fuchs' endothelial corneal dystrophyUNIV TEXAS·Filed 2018·Granted Nov 29, 2022·0 cites·22 claims
- 2257US2015064709A1MODULATING GENE EXPRESSION WITH agRNA AND GAPMERS TARGETING ANTISENSE TRANSCRIPTSUNIV TEXAS·Filed 2014·Application pending·0 cites
- 2357US2024425856A1Compositions and Methods for Treating Cag Repeat DiseasesIRIS MEDICINE INC·Filed 2022·Application pending·0 cites
- 2456US2009092988A1Modulating Gene Expression with agRNA and Gapmers Targeting Antisense TranscriptsSCHWARTZ JACOB C·Filed 2008·Application pending·0 cites
- 2552US11459564B2Modulation of frataxin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Oct 4, 2022·0 cites·23 claims
- 2650US10435430B2Methods and compounds useful in conditions related to repeat expansionIONIS PHARMACEUTICALS INC·Filed 2014·Granted Oct 8, 2019·0 cites·17 claims
- 2750US8999943B2Antigene oligomers inhibit transcriptionCOREY DAVID REID·Filed 2006·Granted Apr 7, 2015·0 cites·20 claims
- 2849US2012288869A1Modulating Gene Expression With agRNA and Gapmers Targeting Antisense TranscriptsSCHWARTZ JACOB C·Filed 2012·Application pending·0 cites
- 2947US2019002876A1Compositions and methods for treatment of friedreich's ataxiaUNIV TEXAS·Filed 2015·Application pending·0 cites
- 3046US2015353936A1Antigene oligomers inhibit transcriptionUNIV TEXAS·Filed 2015·Application pending·0 cites
- 3143US2014128449A1Oligonucleotide modulation of splicingLIU JING·Filed 2012·Application pending·0 cites
- 3240US8815586B2Modulation of gene expression using oligomers that target gene regions downstream of 3′ untranslated regionsCOREY DAVID R·Filed 2010·Granted Aug 26, 2014·0 cites·28 claims
- 3338US2015284716A1Method for single cell sequencing of mirnas and other cellular rnasUNIV TEXAS·Filed 2015·Application pending·0 cites
- 3437US2011110860A1Modulation of ldl receptor gene expression with double-stranded rnas targeting the ldl receptor gene promoterUNIV TEXAS·Filed 2010·Application pending·0 cites
- 3534US2013059902A1Methods and compositions useful in treatment of diseases or conditions related to repeat expansionCOREY DAVID·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David R. Corey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →